NeurologyLive Friday 5 — February 5, 2021

February 5, 2021
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 5, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: The Future of Managing Multiple Sclerosis

Fred Lublin, MD; Patricia K. Coyle, MD; Scott Newsome, DO, MSCS, FAAN; and Mark Freedman, MD, speak to the need for individual prognostication, neuroprotective agents, combination therapy, and the possible use of bone marrow transplantation.

2: Treating Pediatric Migraine With Nerivio REN Device

After Theranica’s remote electrical neuromodulation was approved for those aged 12 years and older with migraine, study investigator Jennifer McVige, MD, MA, shared her insight.

3: AASM’s Strong Recommendation for Cognitive Behavioral Therapy: Jennifer Martin, PhD

The American Academy of Sleep Medicine board of directors member and professor of medicine at UCLA discussed some strengths of CBT in the treatment of insomnia.

4: NeuroVoices: Barbara Karp, MD, and Sharon Meropol, MD, on NeuroCOVID Databank

Barbara Karp, MD, and Sharon Meropol, MD, discuss the recently launched NeuroCOVID databank from the NIH, which will track neurologic symptoms associated with COVID-19.

5: Benefits to Data-Based Registries in ALS: James Berry, MD, MPH

The director of the Massachusetts General Hospital Amyotrophic Lateral Sclerosis Care Center spoke on the importance of data-based registries and how they can grow ALS research.